Pioglitazone Tablet
Product Images NDC 70518-2609

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 70518-2609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pioglitazone 15mg 70518 2609 00

Pioglitazone is a prescription drug that needs to be kept out of reach of children. The drug is manufactured by Rising Pharma, Inc., Allendale, NJ 07401, and repackaged by RemedyRepack Inc., Indiana, PA 15701. The drug can be stored between 20-26°C (63-77°F) with an excursion permitted to 15-30°C (59-86°F) [See USP]. The package insert should be referred to for directions for use. The expiration date and lot number are not available.*

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

The text describes a graph titled "Figure 1" depicting the mean change from baseline for HbAlc in a 26-week placebo-controlled dose-ranging study. The x-axis shows the weeks and the y-axis shows the mean change in values. The graph displays three different doses with observed values: 15mg, 30mg, and 45mg.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.